Margaret Wernsing

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension

Thomas Philipp, Timothy R. Smith, Robert Glazer et al. · Clinical Therapeutics · 2007 · 263 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Serelaxin in Addition to Standard Therapy in Acute Heart Failure: Rationale and Design of the RELAX-AHF-2 Study

John R. Teerlink, Adriaan A. Voors, Piotr Ponikowski et al. · European Journal of Heart Failure · 2017 · 122 citations · Full text

Medicine, Cardiology, Pharmacology +11

Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics

Karola Jering, Brian Claggett, Marc A. Pfeffer et al. · European Journal of Heart Failure · 2021 · 109 citations · Full text

Medicine, Cardiology, Pharmacology +13

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension

Don Poldermans, Robert Glazes, Stefanos Kargiannis et al. · Clinical Therapeutics · 2007 · 98 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Amlodipine and Valsartan Combined and as Monotherapy in Stage 2, Elderly, and Black Hypertensive Patients: Subgroup Analyses of 2 Randomized, Placebo‐Controlled Studies

Timothy R. Smith, Thomas Philipp, George L. Bakris et al. · Journal of Clinical Hypertension · 2007 · 91 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17